Alkem Laboratories

ALKEM

₹ 4,758.11

- ₹ 100.48

2.07%

Healthcare

₹ 0.00

(%)1D

Updated: 01 Jul 2025, 03:31:17 pm IST

Stock Score

Open Price

₹ 4,745.04

Prev. Close

₹ 4,858.59

₹ 4,736.67

Day Low

₹ 4,769.34

Day High

₹ 4,414.76

52 Week Low

₹ 6,390.57

52 Week High

Quick Bite

Price To Earnings Ratio 31.68	Sector PE 52.77
PB Ratio 5.53	Sector PB 7.62
EPS 150.21	Dividend Yield 0.81
Today's Volume 206.966 K	5 Day Avg. Volume 187.604 K
PEG Ratio 0.38	Market Cap. ₹ 58,660.00 Cr.

News & Events

About Alkem Laboratories

Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company's subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.

Alkem Laboratories Share Price

Alkem Laboratories Limited is an Indian company engaged in pharmaceutical business worldwide. The company's field of activity is the development, production and sale of pharmaceutical and nutritional products. The company offers its products in several therapeutic areas such as infectious diseases, dermatology, diabetes, cardiology, gastroenterology, osteoporosis, rheumatology, central nervous system and (CNS), oncology, urology, gynecology and vitamins, minerals and nutrition. Its product portfolio includes Rx Products, Alkem Generics and OTC Products. The company's product range includes brands such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The company operates through the pharmaceutical segment. It has around 21 manufacturing facilities at various locations in India and the United States. The company has approximately 800 brands and operates in 40 countries.

Alkem Laboratories FAQs

How to Buy Alkem Laboratories Share?

To purchase Alkem Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Alkem Laboratories (ticker symbol: ALKEM) on the trading platform provided by your broker and purchase the shares.

What's Alkem Laboratories share price today?

The stock price of Alkem Laboratories as of 05 Jul 2025 is ₹4,758.11

What is the Market Cap of Alkem Laboratories?

Market capitalisation represents the total market value of a company's outstanding shares. As of 05 Jul 2025, Alkem Laboratories (ticker symbol: ALKEM) has a market capitalisation of approximately ₹5,86,60,00,00,000.00

What is the PE and PB ratio of Alkem Laboratories?

Alkem Laboratories Ltd's price-to-book ratio as of 05 Jul 2025 is 5.53, reflecting the market's valuation compared to its asset value. As of 05 Jul 2025, the trailing twelve months P/E (price-to-earnings) ratio is 31.68, indicating the market values the company at around ₹31.68 for every ₹1 of earnings

What is the 52 Week High and Low of Alkem Laboratories Share?

Alkem Laboratories Ltd (ALKEM) hit its 52-week high at ₹6,390.57, and its 52-week low at ₹4,414.76.

Begin your investment journey today

View All Global Indices